National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1254975

History of Changes from the VAERS Wayback Machine

First Appeared on 4/30/2021

VAERS ID: 1254975
VAERS Form:2
Age:0.5
Sex:Unknown
Location:Texas
Vaccinated:2021-03-22
Onset:2021-03-01
Submitted:0000-00-00
Entered:2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8727 / 2 - / OT

Administered by: Private      Purchased by: ??
Symptoms: Fever neonatal, Rash, Illness, Exposure via breast milk

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USPFIZER INC2021387935

Write-up: my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; This is a spontaneous report received from a contactable other healthcare professional. This reporter reported information for both mother and fetus/baby. This is the baby report. Only this case is serious. A 6-months-old patient of an unspecified gender received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via other routed of administration on 22Mar2021 10:00 (Batch/Lot Number: ER8727) as single dose for covid-19 immunisation. Patient received the first dose on 01Mar2021 10:00 with lot number EN6202. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient''s mother reported that separately, her 6 month old, whom she was breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later. Outcome of events was unknown. No follow-up attempts are needed. No further information is expected; Sender''s Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021387880 same reporter/drug, different patient/event(mother case)


Changed on 5/7/2021

VAERS ID: 1254975 Before After
VAERS Form:2
Age:0.5
Sex:Unknown
Location:Texas
Vaccinated:2021-03-22
Onset:2021-03-01
Submitted:0000-00-00
Entered:2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8727 / 2 - / OT

Administered by: Private      Purchased by: ??
Symptoms: Fever neonatal, Rash, Illness, Exposure via breast milk

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USPFIZER INC2021387935

Write-up: my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; This is a spontaneous report received from a contactable other healthcare professional. This reporter reported information for both mother and fetus/baby. This is the baby report. Only this case is serious. A 6-months-old patient of an unspecified gender received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via other routed of administration on 22Mar2021 10:00 (Batch/Lot Number: ER8727) as single dose for covid-19 immunisation. Patient received the first dose on 01Mar2021 10:00 with lot number EN6202. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient''s mother reported that separately, her 6 month old, whom she was breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later. Outcome of events was unknown. No follow-up attempts are needed. No further information is expected; Sender''s Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021387880 same reporter/drug, different patient/event(mother case)


Changed on 5/14/2021

VAERS ID: 1254975 Before After
VAERS Form:2
Age:0.5
Sex:Unknown
Location:Texas
Vaccinated:2021-03-22
Onset:2021-03-01
Submitted:0000-00-00
Entered:2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8727 / 2 - / OT

Administered by: Private      Purchased by: ??
Symptoms: Fever neonatal, Rash, Illness, Exposure via breast milk

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USPFIZER INC2021387935

Write-up: my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; my 6 month old, whom I am breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later; This is a spontaneous report received from a contactable other healthcare professional. This reporter reported information for both mother and fetus/baby. This is the baby report. Only this case is serious. A 6-months-old patient of an unspecified gender received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via other routed of administration on 22Mar2021 10:00 (Batch/Lot Number: ER8727) as single dose for covid-19 immunisation. Patient received the first dose on 01Mar2021 10:00 with lot number EN6202. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient''s mother reported that separately, her 6 month old, whom she was breastfeeding, became sick with a moderate fever for 3 days and then a rash about a week about 10 days later. Outcome of events was unknown. No follow-up attempts are needed. No further information is expected; Sender''s Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021387880 same reporter/drug, different patient/event(mother case)

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1254975&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166